Hänninen A, Taylor C, Streeter P R, Stark L S, Sarte J M, Shizuru J A, Simell O, Michie S A
National Public Health Institute, University of Turku, Finland.
J Clin Invest. 1993 Nov;92(5):2509-15. doi: 10.1172/JCI116859.
In the nonobese diabetic (NOD) mouse, lymphocytic and monocytic infiltration of the pancreatic islets leads to beta cell destruction. To investigate the mechanisms by which lymphocytes enter the NOD pancreas, pancreata were immunostained using monoclonal antibodies to a variety of adhesion molecules known to be involved in lymphocyte binding to vascular endothelium, an initial step in the migration of lymphocytes from blood into organized lymphoid and inflamed tissues. These adhesion molecules include: lymphocyte homing receptors involved in tissue-selective binding of lymphocytes to peripheral lymph node (L-selectin) or mucosal lymphoid tissue (LPAM-1, alpha 4 beta 7-integrin) high-endothelial venules (HEV); and HEV ligands peripheral vascular addressin (PNAd) and mucosal vascular addressin (MAdCAM-1). In NOD pancreata, alpha 4 beta 7 is expressed on most infiltrating cells at all stages of insulitis, whereas L-selectin expression is more pronounced on cells in the islets at later stages. During the development of insulitis, MAdCAM-1 and to a lesser extent PNAd became detectable on vascular endothelium adjacent to and within the inflamed islets. The Stamper-Woodruff in vitro assay was used to examine lymphoid cell binding to such vessels. These functional assays show that both the mucosal (MAdCAM-1/alpha 4 beta 7) and the peripheral (PNAd/L-selectin) recognition systems are involved in this binding. Our findings demonstrate that expression of peripheral and mucosal vascular addressins is induced on endothelium in inflamed islets in NOD pancreas, and that these addressins participate in binding lymphoid cells via their homing receptors. This suggests that these adhesion molecules play a role in the pathogenesis of diabetes in these mice by being involved in the migration of lymphocytes from blood into the inflamed pancreas.
在非肥胖型糖尿病(NOD)小鼠中,胰岛的淋巴细胞和单核细胞浸润会导致β细胞破坏。为了研究淋巴细胞进入NOD胰腺的机制,使用针对多种已知参与淋巴细胞与血管内皮结合的粘附分子的单克隆抗体对胰腺进行免疫染色,淋巴细胞从血液迁移到有组织的淋巴组织和炎症组织的第一步就是与血管内皮结合。这些粘附分子包括:参与淋巴细胞与外周淋巴结(L-选择素)或粘膜淋巴组织(LPAM-1,α4β7整合素)高内皮微静脉(HEV)进行组织选择性结合的淋巴细胞归巢受体;以及HEV配体外周血管地址素(PNAd)和粘膜血管地址素(MAdCAM-1)。在NOD胰腺中,α4β7在胰岛炎各个阶段的大多数浸润细胞上表达,而L-选择素在后期胰岛细胞上的表达更为明显。在胰岛炎发展过程中,在炎症胰岛附近和内部的血管内皮上可检测到MAdCAM-1,PNAd的检测程度较低。使用斯坦珀-伍德拉夫体外试验来检测淋巴细胞与这类血管的结合。这些功能试验表明,粘膜(MAdCAM-1/α4β7)和外周(PNAd/L-选择素)识别系统均参与这种结合。我们的研究结果表明,外周和粘膜血管地址素在NOD胰腺炎症胰岛的内皮上被诱导表达,并且这些地址素通过其归巢受体参与淋巴细胞的结合。这表明这些粘附分子通过参与淋巴细胞从血液迁移到炎症胰腺中,在这些小鼠的糖尿病发病机制中发挥作用。